CWA
ABBV icon

Centennial Wealth Advisory’s AbbVie ABBV Stock Holding History

Centennial Wealth Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
2,331
+77
+3% +$16.6K 0.13% 114
2026
Q1 		$491K Buy
2,254
+137
+6% +$30.4K 0.12% 105
2025
Q4 		$484K Buy
2,117
+28
+1% +$6.38K 0.13% 114
2025
Q3 		$484K Buy
2,089
+45
+2% +$9.16K 0.13% 109
2025
Q2 		$381K Sell
2,044
-65
-3% -$12.1K 0.12% 118
2025
Q1 		$442K Buy
2,109
+80
+4% +$15.6K 0.16% 90
2024
Q4 		$361K Sell
2,029
-169
-8% -$31.1K 0.14% 99
2024
Q3 		$434K Buy
2,198
+471
+27% +$87.9K 0.17% 76
2024
Q2 		$296K Buy
1,727
+368
+27% +$61K 0.13% 101
2024
Q1 		$248K Buy
+1,359
New +$234K 0.11% 121

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Centennial Wealth Advisory's ABBV Position: Q2 2026 in Review

Centennial Wealth Advisory increased its AbbVie (ABBV) stake by 3.4% in Q2 2026, buying an estimated $16.6K and bringing the position to 2,331 shares worth $587K. The position accounts for 0.13% of the portfolio, ranked #114.

Centennial Wealth Advisory first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Centennial Wealth Advisory held 2,331 shares of AbbVie worth $587K as of Q2 2026.
  • Centennial Wealth Advisory bought 77 AbbVie shares in Q2 2026, an estimated $16.6K.
  • AbbVie made up 0.13% of Centennial Wealth Advisory's portfolio in Q2 2026, its #114 holding.
  • Centennial Wealth Advisory first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.